Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Long-Term Clinical and Molecular Remissions in Patients with Mantle Cell Lymphoma (MCL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Bernd Metzner, MD PhD, Jochen Casper, MD PhD, Koehne Claus-Henning, MD PhD, Andrea Renzelmann, MD, Thomas H. Mueller, MD PhD, Eduard K. Petershofen, MD PhD, Bernd Rosien, MD, Ruth Thole, MD, Andreas Voss, MD, Martin H. Dreyling, MD PhD, Eva Hoster, PhD, Wolfram Klapper, Christiane Pott, MD PhD

Blood (2019) 134 (Supplement_1): 2819.

https://doi.org/10.1182/blood-2019-122353

Published: 2019

Journal Articles

Incidence and Outcomes Associated with Distal Deep Vein Thrombosis in 760,344 Patients with 13 Common Malignancies

Richard H White, MD, Ann M Brunson, MS, Anjlee Mahajan, MD, Theresa H.M. Keegan, PhD MS, Ted Wun, MD

Blood (2018) 132 (Supplement 1): 2526.

https://doi.org/10.1182/blood-2018-99-110872

Published: 2018

Journal Articles

Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma

Mary H Young, PhD, Sam A Danziger, Alison Fitch, Frank Schmitz, MD PhD, Jake Gockley, PhD, Mark McConnell, PhD, David Reiss, PhD, Wilbert B. Copeland, PhD, Sarah K Johnson, PhD, Katie Newhall, PhD, Robert Hershberg, MD PhD, Teri Foy, PhD, Alexander Ratushny, PhD, Brian A Walker, PhD, Andrew Dervan, Gareth Morgan, MD

Blood (2018) 132 (Supplement 1): 243.

https://doi.org/10.1182/blood-2018-99-113042

Published: 2018

Journal Articles

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Jeffrey A Zonder, MD, Vaishali Sanchorawala, MD, Vishal Kukreti, MD FRCP(C), Sascha A Tuchman, MD, Yubin Kang, MD, Divaya Bhutani, MD, Steven Burt, ANP, Christiane Houde, BS, Kathy A. Reichel, Silva Pregja, MBA, Jeffrey V Matous, MD

Blood (2017) 130 (Supplement 1): 3158.

https://doi.org/10.1182/blood.V130.Suppl_1.3158.3158

Published: 2017

Journal Articles

Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Bernd Metzner, MD, PhD, Bernd Rosien, MD, Jochen Casper, MD, PhD, Claus-Henning Köhne, MD, PhD, Doris M. Kraemer, MD, PhD, Thomas H. Mueller, MD, PhD, Andrea Renzelmann, MD, Ruth Thole, MD, Christiane Pott, MD, PhD

Blood (2017) 130 (Supplement 1): 4539.

https://doi.org/10.1182/blood.V130.Suppl_1.4539.4539

Published: 2017

Journal Articles

Changes in Second Primary Malignancies (SPM) after Hodgkin Lymphoma over Time in the United States

Amy Steele, BS, Qian Li, MS, Ann M Brunson, MS, Aaron S. Rosenberg, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 4097.

https://doi.org/10.1182/blood.V130.Suppl_1.4097.4097

Published: 2017

Journal Articles

Long-Term Follow-up of the ALLG CML8 Twister Study of Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia (CML)

David M Ross, MBBS, PhD FRACP, FRCPA, Ilaria S Pagani, PhD, Naranie Shanmuganathan, MBBS, John F Seymour, MBBS, PhD, Anthony K Mills, FRACP, FRCPA, MBBS, Robin J Filshie, PhDFRACP,FRCPA, Christopher K Arthur, MDFRACP,FRCPA,MBBS, Phuong Dang, Verity A Saunders, Jody Braley, David T Yeung, PhDBSc,FRACP,FRCPA,MBBS, Deborah L White, PhD FFSc (RCPA), Andrew P Grigg, MBBS, MD FRACP, FRCPA, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Susan Branford, PhD, Timothy P. Hughes, MD

Blood (2017) 130 (Supplement 1): 1597.

https://doi.org/10.1182/blood.V130.Suppl_1.1597.1597

Published: 2017

Journal Articles

Long-Term Outcome of a Prospective Study of Bortezomib, Dexamethasone and Rituximab (BDR) in Previously Untreated, Symptomatic Patients with Waldenstrom's Macroglobulinemia

Steven P Treon, MD PhD, Kirsten Meid, MPH, Joshua Gustine, MPH, Christopher J Patterson, MFA, Jeffrey V. Matous, MD, Irene M. Ghobrial, MD, Jorge J Castillo, MD

Blood (2015) 126 (23): 1833.

https://doi.org/10.1182/blood.V126.23.1833.1833

Published: 2015

Journal Articles

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Robert M. Rifkin, MD, Rafat Abonour, MD, Jatin J. Shah, MD, Jayesh Mehta, MD, Mohit Narang, MD, Howard R. Terebelo, DO, Cristina J Gasparetto, MD, Sachdev P. Thomas, MD, Kathleen Toomey, MD, James W Hardin, PhD, Jane Jie Lu, MS, Laurie Kenvin, BSN, RN, Shankar Srinivasan, PhD, Rosanna J. Ricafort, MD, Yasir Nagarwala, MD, Brian G. M. Durie, MD

Blood (2014) 124 (21): 4749.

https://doi.org/10.1182/blood.V124.21.4749.4749

Published: 2014

Journal Articles

Natural History Of Smoldering Monoclonal Gammopathy-Associated Malignancies: A Population-Based Study

Ronald S. Go, MD, Jacob D Gundrum, MS, Joan M Neuner, MD

Blood (2013) 122 (21): 5318.

https://doi.org/10.1182/blood.V122.21.5318.5318

Published: 2013

Journal Articles

Risk of Second Primary Malignancies in Patients with AL Amyloidosis Treated with Lenalidomide

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Gheorghe Doros, PhD, David C Seldin, MD, PhD

Blood (2012) 120 (21): 1873.

https://doi.org/10.1182/blood.V120.21.1873.1873

Published: 2012

Journal Articles

Second Malignancies After Autologous Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Girindra Raval, Anuj Mahindra, MD, Xiaobo Zhong, MS, Ruta Brazauskas, PhD, Robert Peter Gale, MD, PhD, DSc, FACP, Nancy Brandenburg, PhD, Sagar Lonial, MD, Amrita Krishnan, MD, Angela Dispenzieri, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2012) 120 (21): 591.

https://doi.org/10.1182/blood.V120.21.591.591

Published: 2012

Journal Articles

Cancer Complications At the Time of Multiple Myeloma Diagnosis and the Impact of Monoclonal Gammopathy of Undetermined Significance (MGUS) Follow-up: A Population-Based Study

Jacob D Gundrum, MS, Joan M Neuner, MD, Ronald S. Go, MD

Blood (2012) 120 (21): 3996.

https://doi.org/10.1182/blood.V120.21.3996.3996

Published: 2012

Journal Articles

Second Malignancies Among Elderly Multiple Myeloma Patients Exposed to Bortezomib and Other Treatments: An Analysis of the US SEER-Medicare Linked Database,

Dina Gifkins, PhD, Megan McAuliffe, ScD, Amy Matcho, BS, Jane Porter, MS, Scott Chavers, PhD, Maria Ponsillo, MD, Jay King, MD, Avinash Desai, MD, Andrew Cakana, MD, Dixie-Lee Esseltine, MD

Blood (2011) 118 (21): 3972.

https://doi.org/10.1182/blood.V118.21.3972.3972

Published: 2011

Journal Articles

Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes

Aristoteles Giagounidis, MD, Azra Raza, MD, Alan F. List, MD, Pierre Fenaux, MD, PhD, Bouchra Benettaib, MD, Benton Brown, MD, Jim Zhong, PhD, Nancy Brandenburg, PhD, Ghulam J. Mufti, MD

Blood (2011) 118 (21): 1704.

https://doi.org/10.1182/blood.V118.21.1704.1704

Published: 2011

Journal Articles

Unique Gain-of-Function of Mutated c-CBL Tumor Suppresor in Myeloid Neoplasms.

Blood (2009) 114 (22): 2970.

https://doi.org/10.1182/blood.V114.22.2970.2970

Published: 2009

Journal Articles

Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein with In Vitro and In Vivo Activity Against Non-Hodgkin’s Lymphoma and Other Hematologic Malignancies.

Mireille Guerin, Cynthia Therien, Gorazd Krosl, Jinzi J. Wu, Helene Dulude, Chandra Panchal, Denis-Claude Roy

Blood (2007) 110 (11): 1388.

https://doi.org/10.1182/blood.V110.11.1388.1388

Published: 2007

Journal Articles

Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL).

Emilio Iannitto, MD, Stefano De Cantis, PhD, Viviana Minardi, MD, Vincenzo Callea, MD, Giuseppina Calvaruso, MD, Antonino Mulè, MD, Emanuele Ammatuna, MD, Caterina Stelitano, MD, Claudio Tripodo, MD, Achille Ambrosetti, MD, Giovanni Pizzolo, MD, Ada Florena, MD, Vito Franco, MD, Ada Florena, MD

Blood (2004) 104 (11): 4536.

https://doi.org/10.1182/blood.V104.11.4536.4536

Published: 2004

Journal Articles

Second Cancers after CLL Diagnosis.

Yun Gu, MS, Sara S. Strom, PhD, Susan Lerner, MS, Michael J. Keating, MD

Blood (2004) 104 (11): 18.

https://doi.org/10.1182/blood.V104.11.18.18

Published: 2004

Journal Articles

Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work

Marcos de Lima, Sara S. Strom, Michael Keating, Hagop Kantarjian, Sherry Pierce, Susan O'Brien, Emil Freireich, Elihu Estey

Blood (1997) 90 (12): 4719–4724.

https://doi.org/10.1182/blood.V90.12.4719

Published: 1997

NARROW

Long-Term Clinical and Molecular Remissions in Patients with Mantle Cell Lymphoma (MCL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Incidence and Outcomes Associated with Distal Deep Vein Thrombosis in 760,344 Patients with 13 Common Malignancies

Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma

Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis

Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Changes in Second Primary Malignancies (SPM) after Hodgkin Lymphoma over Time in the United States

Long-Term Follow-up of the ALLG CML8 Twister Study of Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia (CML)

Long-Term Outcome of a Prospective Study of Bortezomib, Dexamethasone and Rituximab (BDR) in Previously Untreated, Symptomatic Patients with Waldenstrom's Macroglobulinemia

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Natural History Of Smoldering Monoclonal Gammopathy-Associated Malignancies: A Population-Based Study

Risk of Second Primary Malignancies in Patients with AL Amyloidosis Treated with Lenalidomide

Second Malignancies After Autologous Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Cancer Complications At the Time of Multiple Myeloma Diagnosis and the Impact of Monoclonal Gammopathy of Undetermined Significance (MGUS) Follow-up: A Population-Based Study

Second Malignancies Among Elderly Multiple Myeloma Patients Exposed to Bortezomib and Other Treatments: An Analysis of the US SEER-Medicare Linked Database,

Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes

Unique Gain-of-Function of Mutated c-CBL Tumor Suppresor in Myeloid Neoplasms.

Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein with In Vitro and In Vivo Activity Against Non-Hodgkin’s Lymphoma and Other Hematologic Malignancies.

Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL).

Second Cancers after CLL Diagnosis.

Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only